| 000 | 01886 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514222722.0 | ||
| 264 | 0 | _c20050609 | |
| 008 | 200506s 0 0 eng d | ||
| 022 | _a0021-9525 | ||
| 024 | 7 |
_a10.1083/jcb.200501048 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHenkler, Frank | |
| 245 | 0 | 0 |
_aThe extracellular domains of FasL and Fas are sufficient for the formation of supramolecular FasL-Fas clusters of high stability. _h[electronic resource] |
| 260 |
_bThe Journal of cell biology _cMar 2005 |
||
| 300 |
_a1087-98 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdaptor Proteins, Signal Transducing _xgenetics |
| 650 | 0 | 4 |
_aApoptosis _xphysiology |
| 650 | 0 | 4 | _aCaspase 8 |
| 650 | 0 | 4 |
_aCaspases _xgenetics |
| 650 | 0 | 4 |
_aCytoplasm _xmetabolism |
| 650 | 0 | 4 |
_aExtracellular Space _xmetabolism |
| 650 | 0 | 4 | _aFas Ligand Protein |
| 650 | 0 | 4 | _aFas-Associated Death Domain Protein |
| 650 | 0 | 4 | _aHeLa Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMacromolecular Substances _xmetabolism |
| 650 | 0 | 4 |
_aMembrane Glycoproteins _xchemistry |
| 650 | 0 | 4 |
_aMembrane Microdomains _xmetabolism |
| 650 | 0 | 4 |
_aMutation _xphysiology |
| 650 | 0 | 4 |
_aProtein Binding _xphysiology |
| 650 | 0 | 4 |
_aProtein Structure, Tertiary _xphysiology |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aSolubility _xdrug effects |
| 650 | 0 | 4 |
_abeta-Cyclodextrins _xpharmacology |
| 650 | 0 | 4 |
_afas Receptor _xchemistry |
| 700 | 1 | _aBehrle, Eva | |
| 700 | 1 | _aDennehy, Kevin M | |
| 700 | 1 | _aWicovsky, Andreas | |
| 700 | 1 | _aPeters, Nathalie | |
| 700 | 1 | _aWarnke, Clemens | |
| 700 | 1 | _aPfizenmaier, Klaus | |
| 700 | 1 | _aWajant, Harald | |
| 773 | 0 |
_tThe Journal of cell biology _gvol. 168 _gno. 7 _gp. 1087-98 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1083/jcb.200501048 _zAvailable from publisher's website |
| 999 |
_c15466033 _d15466033 |
||